Jump to content

Temazepam: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
m →‎Utilisation: american spelling for consistency
Thegoodson (talk | contribs)
2,034 edits
Line 129: Line 129:


==Side effects==
==Side effects==

'''Common side effects include:'''
===Common side effects include===
[[Central nervous system|CNS]] depression typical of hypnotic benzodiazepine are common and include, [[somnolence]], [[dizziness]], [[Fatigue (medical)|fatigue]], [[ataxia]], [[headache]], [[lethargy]], impairment of memory, impairment of motor functions, slurred speech, decreased physical performance, numbed emotions, reduced alertness, muscle weakness, blurred vision, and inattention. [[Euphoria]], which is very uncommon among the vast majority of benzodiazepines, was consistently reported with the use of temazepam. According to the [[Food and Drug Administration|FDA]], temazepam had one of the highest incidences of euphoria among the few benzodiazepines that reported it during clinical trials.<ref>http://www.drugs.com/pro/temazepam.html</ref>. Unpleasant dreams and rebound insomnia have also been reported. High levels of [[confusion]], [[clumsiness]] also occurs after administration of temazepam.<ref>{{cite journal | author = Sanders LD | coauthors = Yeomans WA, Rees J, Rosen M, Robinson JO. | year = 1988 | month = Nov | title = A double-blind comparison between nitrazepam, lorazepam, lormetazepam and placebo as preoperative night sedatives. | journal = Eur J Anaesthesiol. | volume = 5 | issue = 6 | pages = 377-83 | pmid = 2907315 }}</ref> Increased reaction time, co-ordination problems and impaired learning and memory.<ref>{{cite journal | author = Liljequist R | coauthors = Mattila MJ. | year = 1979 | month = May | title = Acute effects of temazepam and nitrazepam on psychomotor skills and memory. | journal = Acta Pharmacol Toxicol (Copenh). | volume = 44 | issue = 5 | pages = 364-9 | pmid = 38627 }}</ref>

* [[Somnolence]]
* [[Somnolence]]
*Impaired motor function
*Impaired motor function
Line 144: Line 147:
* Slurred speech
* Slurred speech


==Less Common Side Effects===
'''Rare side effects include:'''
[[Hyperhidrosis]], [[hypotension]], burning eyes, changes in [[libido]], hallucinations, faintness, horizontal nystagmus, vomiting, [[pruritus]], gastrointestinal disturbances, nightmares, [[palpitation]] and paradoxical reactions including restlessness, aggression, violence, overstimulation and agitation have been reported, but are rare (less than 0.5%).
* Neurological - Agitation, aggression, anxiety, headache, depression, hallucinations, hangover, increased dreaming, loss of equilibrium, nightmares, restlessness, vertigo
* Cardiovascular - Cardiac arrhythmia
* Respiratory - Severe respiratory depression, hypoventilation
* Gastrointestinal - Abdominal discomfort, diarrhea, vomiting
* Ocular - Burning sensation in eyes, nystagmus
* Other - Abnormal sweating, backache, dry mouth, muscular weakness


Before taking temazepam, one should ensure that at least 8 hours are available to dedicate to sleep. Failing to do so can increase the side effects of the drug.
Before taking temazepam, one should ensure that at least 8 hours are available to dedicate to sleep. Failing to do so can increase the side effects of the drug.
Line 156: Line 154:
Long-term use of temazepam can result in psychological and physical dependence and the appearance of [[benzodiazepine withdrawal symptoms]] when the drug is discontinued or the dose reduced. Temazepam impairs [[cognitive]] and psychomotor functions, affecting reaction time and driving skill. The use of this drug in combination with alcohol potentiates these side effects, and can lead to [[toxicity]] and [[death]].
Long-term use of temazepam can result in psychological and physical dependence and the appearance of [[benzodiazepine withdrawal symptoms]] when the drug is discontinued or the dose reduced. Temazepam impairs [[cognitive]] and psychomotor functions, affecting reaction time and driving skill. The use of this drug in combination with alcohol potentiates these side effects, and can lead to [[toxicity]] and [[death]].


Residual 'hangover' effects after nighttime administration of temazepam such as sleepiness, impaired psychomotor and [[cognitive]] functions may persist into the next day which may impair the ability of users to drive safely or may increase the risks of falls and [[hip fractures]].<ref>{{cite journal | author = Vermeeren A. | coauthors = | year = 2004 | month = | title = Residual effects of hypnotics: epidemiology and clinical implications. | journal = CNS Drugs. | volume = 18 | issue = 5 | pages = 297-328 | pmid = 15089115 }}</ref>
Though rare, residual 'hangover' effects after nighttime administration of temazepam such as sleepiness, impaired psychomotor and [[cognitive]] functions may persist into the next day which may impair the ability of users to drive safely or may increase the risks of falls and [[hip fractures]].<ref>{{cite journal | author = Vermeeren A. | coauthors = | year = 2004 | month = | title = Residual effects of hypnotics: epidemiology and clinical implications. | journal = CNS Drugs. | volume = 18 | issue = 5 | pages = 297-328 | pmid = 15089115 }}</ref>


==Interactions==
==Interactions==

Revision as of 18:44, 20 November 2007

Temazepam
Clinical data
Pregnancy
category
  • AU: X (High risk)
Routes of
administration		Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability96%
MetabolismHepatic
Elimination half-life8-20 hours
ExcretionRenal
Identifiers
  • 7-Chloro-1,3-dihydro-
    3-hydroxy-1-methyl-5-phenyl-
    1,4-benzodiazepin-2-one
CAS Number
PubChem CID
DrugBank
CompTox Dashboard (EPA)
ECHA InfoCard100.011.535 Edit this at Wikidata
Chemical and physical data
FormulaC16H13ClN2O2
Molar mass300.7 g/mol g·mol−1

Temazepam (marketed under brand names Restoril®, Euhypnos®, Normison®, Remestan®, Planum®, Tenox® and Norkotral®) is a benzodiazepine drug which belongs to the sub-class of hypnotic benzodiazepines, and as such, it is a powerful hypnotic drug which possesses particularly strong sedative, amnestic and motor impairing properties.[1] In addition, temazepam also has strong anxiolytic, anticonvulsant, and skeletal muscle relaxant properties. Temazepam, which is an intermediate acting benzodiazepine, acts quickly to induce sleep. It is generally prescribed for the treatment of short-term severe or debilitating insomnia in patients who have difficulty falling asleep or maintaining sleep.[2]

History

Temazepam was first synthesized in the mid 1960's, and by the year 1969, the Food and Drug Administration approved temazepam as a sedative-hypnotic for the treatment of insomnia and other sleep disorders under the trade name Restoril®. Its powerful sedative and amnesic effects got the attention of several Secret Intelligence agencies, especially the former Soviet Union. It was utilized as a truth serum during interrogations because of its strong hypnotic properties. Given to the subject, temazepam weakens the resolve of the subject and makes him or her more compliant to pressure. As a truth serum, temazepam was not often used. It was mainly utilized by the Soviet Union and East Germany in the 1970's during the Cold War. It also saw limited use as a truth serum in some parts of East Asia and Southeast Asia. The preferred drugs used as truth serums were, and still are barbiturates, particularly sodium thiopental (Sodium Pentothal). Temazepam was also one of several drugs used in the research of mind control, brainwashing and mass-scale social engineering by Secret Intelligence agencies of several different federal governments. Other drugs used for this same purpose were, barbiturates, morphine, LSD, amphetamines, and neuroleptics. [3] In former Soviet Union, temazepam was extensively used, along with other drugs like haloperidol (Haldol), thorazine, barbiturates, and morphine to keep political dissidents housed in psikhushkas (mental asylums and psychiatric hospitals) in a constant vegetative state. [4] [5]

By the late 1980's, temazepam was one of the most effective hypnotics on the market and it became one of the most widely prescribed drugs for insomnia and other sleep disorders. With that however, the abuse of temazepam became widespread in much of Europe, East and Southeast Asia, Australia and New Zealand. It quickly superseded other benzodiazepines like diazepam (Valium®) and nitrazepam (Mogadon®), which were also commonly diverted to the black market and abused by drug seekers. In North America, its abuse did not become as widespread as it did elsewhere in the world due to the fact that in the years between 1985-1996 the most commonly prescribed hypnotic in the United States and Canada was triazolam. Diazepam, though not a hypnotic and isn't usually indicated for sleep, was also more widely prescribed to patients having trouble sleeping then was temazepam.[6]

Until recently, temazepam was produced as a gel-filled capsule intended to be taken orally. However, it gained notoriety in Europe, especially in United Kingdom and Scotland, when it was discovered that if the capsules were melted and injected, the effects were more powerful and the onset was quicker. However, the liquid has a tendency to congeal in arteries and cause thrombosis and gangrene, in some cases requiring amputation. Despite the risks, injection of temazepam quickly spread throughout some parts Europe and then to Australia, New Zealand, and many parts of Asia. In Malaysia, nimetazepam is the only benzodiazepine that's more commonly abused or sought after by drug seekers than temazepam. To curb the diversion of temazepam into the black market and stop abuse, many countries have placed temazepam under more strict drug schedules. In Australia, instead of being a Schedule 4 drug like all other benzodiazepines, temazepam is placed in Schedule 8, along side drugs like morphine, cocaine, methamphetamine, and methylphenidate (Ritalin®). In the United Kingdom, temazepam (and flunitrazepam) is a Class B drug, meanwhile all other benzodiazepines are Class C, a much less restrictive category. In the United States, temazepam is the only benzodiazepine which requires specially coded prescriptions in certain states.[7] Despite the much more stringent restrictions put on temazepam compared to most other benzodiazepines, temazepam remains to be the most sought after and abused benzodiazepine worldwide with more kilograms of diverted temazepam being seized than any other benzodiazepine, followed by flunitrazepam, nitrazepam, nimetazepam, and then diazepam.[8] Pharmacy burglaries and prescription forgeries in England, Australia, Ireland, Sweden, and several Asian countries report that temazepam is often a main target, whilst other benzodiazepines are rarely targetted.[9][10][11]

Pharmacology

Temazepam is a 1,4 benzodiazepine with the chemical name 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1-4-benzodiazepin-2-one. It is lipophilic and is metabolized hepatically via oxidative pathways. The main pharmacological action of temazepam is the enhancement of the neurotransmitter, GABA at the GABAA receptor.[12] The half life of temazepam is 8-22 hours.[13]

Temazepam is an active benzodiazepine and a powerful hypnotic agent. In sleep laboratory studies, temazepam dramatically decreased the number of nightly awakenings. Rebound insomnia was observed only occasionally after withdrawal of the drug. Temazepam decreased stage 3, and combined stage 3 and 4 sleep, accompanied by a compensatory increase in stage 2 sleep, but did not alter REM sleep.

Orally administered temazepam is well absorbed in humans. The onset of effects are rapid and are typically felt within 30 minutes. Temazepam has a half-life of about 8 to 10 hours in plasma (with considerable inter-individual variability). On multiple dosing, steady state is reached usually within 3 to 5 days with excretion of the drug mainly in the urine in the form of the inactive O-conjugate metabolite.

The elimination half life of temazepam increases in the elderly which may result in prolonged action.[14]

Temazepam has been found to be dangerous in elderly patients due to a significant increased risk of falls.[15] Temazepam shares cross tolerance with barbiturates and barbiturates can easily be subsituted for temazepam in those who are habituated to barbiturate sedative hypnotics.[16]

Pharmacokinetics

In a single and multiple dose absorption, distribution, metabolism, and excretion (ADME) study, using tritium (3H) labeled drug, temazepam was well absorbed and found to have minimal (8%) first pass metabolism. There were no active metabolites formed and the only significant metabolite present in blood was the O-conjugate. The unchanged drug was 96% bound to plasma proteins. The blood level decline of the parent drug was biphasic with the short half-life ranging from 0.4-0.6 hours and the terminal half-life from 3.5-18.4 hours (mean 8.8 hours), depending on the study population and method of determination.[17] Metabolites were formed with a half-life of 10 hours and excreted with a half-life of approximately 2 hours. Thus, formation of the major metabolite is the rate limiting step in the biodisposition of temazepam. There is no accumulation of metabolites. A dose-proportional relationship has been established for the area under the plasma concentration/time curve over the 15-30 mg dose range.[18]

Temazepam was completely metabolized through conjugation prior to excretion; 80%-90% of the dose appeared in the urine. The major metabolite was the O-conjugate of temazepam (90%); the O-conjugate of N-desmethyl temazepam was a minor metabolite (7%).[19]

Bioavailability, Induction, and Plasma Levels

After oral administration, temazepam is rapidly absorbed and fast acting. Following ingestion of 30 mg temazepam, measurable plasma concentrations are achieved 10-20 minutes after dosing with peak plasma levels ranging from 666-982 ng/mL (mean 865 ng/mL) occurring approximately 1.2-1.6 hours (mean 1.5 hours) after dosing. Strong hypnotic, sedative and anticonvulsant effects are noticeable 20-30 minutes after ingestion.[20]

In a 7 day study, in which subjects were given a 30 mg temazepam capsule 1 hour before retiring, steady-state (as measured by the attainment of maximal trough concentrations) was achieved by the third dose. Mean plasma levels of temazepam (for days 2-7) were 260±210 ng/mL at 9 hours and 75±80 ng/mL at 24 hours after dosing. A slight trend toward declining 24 hour plasma levels was seen after day 4 in the study, however, the 24 hour plasma levels were quite variable.[21]

At a dose of 30 mg once-a-day for 8 weeks, no evidence of enzyme induction was found in man.

Indications

Temazepam is often prescribed for severe insomnia for short periods of time (usually no more than 7-10 days) and other severe or disabling sleep disorders. Temazepam taken for longer than 2 - 4 weeks may result in a strong physical dependence with a resultant benzodiazepine withdrawal syndrome developing when dosage is decreased or the drug is stopped. Temazepam is considered to be one of the most addictive of the benzodiazepines and thus not suited for long-term treatment.

Military Use

The United States Air Force uses temazepam under trade name Restoril as "no-go pills" to help pilots sleep after a mission. Another drug used for the same purpose is a short acting nonbenzodiazepine zolpidem (Ambien) (Cf. "go-pills"; dextroamphetamine, or recently modafinil, used as a stimulant for pilots).

Utilization

Temazepam, despite being the most highly restricted benzodiazepine in Australia (along with flunitrazepam) is commonly prescribed for severe insomnia. Temazepam along with diazepam, nitrazepam and oxazepam represent 82% of the benzodiazepine market in Australia.[22]

Dosage

File:Temazepam DOJ.jpg

When used for treatment of insomnia, the usual dose is 7.5mg to 15mg taken at bedtime but can be used at doses up to 30mg.

In the United States, temazepam is available in 7.5mg, 15mg, 22.5mg and 30mg capsules.

It is available as 10 and 20mg tablets in Finland, but also in at least some countries in the rest of Europe.

In the United Kingdom Temazepam is currently available in doses of 10mg and 20mg tablets.

In Australia it is only available in 10mg tablets under the trade name "Normison" and the generic name "Temaze" and "Temtabs". 20mg tablets and Temazepam in capsule or gelcap form is no longer available in that country.

Usual UK doses (from BNF) are 10-20mg at bedtime, max 30-40mg in exceptional circumstances.

Tolerance

Tolerance to temazepam's sleep promoting effects occurs rapidly. A study found that quality of sleep was increased after the first nights administration of either nitrazepam or temazepam but by day 7 quality of sleep was found to have returned to baseline suggesting the development of tolerance.[23]

Dependence

Temazepam as with other benzodiazepine drugs can lead to physical dependence, addiction and what is known as the benzodiazepine withdrawal syndrome. Withdrawal from temazepam or other benzodiazepines after regular use often leads to withdrawal symptoms which are similar to those seen during alcohol and barbiturate withdrawal. The higher the dose and the longer the drug is taken for the greater the risk of experiencing unpleasant withdrawal symptoms. Withdrawal symptoms can however occur from standard dosages and also after short term use. Benzodiazepine treatment should be discontinued as soon as possible via a slow and gradual dose reduction regime.[24] Dependence on temazepam and other benzodiazepine hypnotics like nitrazepam, flunitrazepam, or nimetazepam often occurs due to discharging patients from hospital on benzodiazepines who were started on benzodiazepine hypnotics in hospital. It was recommended that hypnotics in hospital be limited to 5 nights use only to avoid the development of the benzodiazepine withdrawal syndrome eg withdrawal insomnia.[25]

After discontinuation of temazepam, a rebound effect may occur immediately after abruptly stopping.[26] Temazepam tends to have more side effects than other hypnotic drugs and tolerance to the sedative properties and rebound insomnia after discontinuation occurs after only 3-5 days administration.[27] Tolerance to the anticonvulsant and anxiolytic effects also develops rapidly during daily administration.[28]

Abrupt withdrawal after long term use from therapeutic doses of temazepam may result in a very severe benzodiazepine withdrawal syndrome. There are reports in the medical literature of at least six psychotic states developing after abrupt withdrawal from temazepam including delirium after abrupt withdrawal of only 30 mg of temazepam and in another case, auditory hallucinations and visual cognitive disorder developed after abrupt withdrawal from 10 mg of temazepam, 5 mg of nitrazepam and 0.5 mg of triazolam. Gradual and careful reduction of the dosage, preferably with a milder benzodiazepine such as clonazepam, oxazepam, alprazolam or the long-acting, diazepam was recommended to prevent severe withdrawal syndromes from developing. [29] Antipsychotics increase the severity of benzodiazepine withdrawal effects with an increase in the intensity and severity of convulsions.[30] Depersonalisation has also been reported as a benzodiazepine withdrawal effect from temazepam.[31]

Abrupt withdrawal from very high doses is even more likely to cause severe withdrawal effects. Withdrawal from very high doses of temazepam will cause severe hypoperfusion of the whole brain with diffuse slow activity on EEG. After withdrawal, abnormalities in hypofrontal brain wave patterns may persist beyond the withdrawal syndrome suggesting that organic brain damage may occur from chronic high dose abuse of temazepam. Temazepam withdrawal has been well known to cause a sudden and often violent death.[32]

Cognitive Behavioural Therapy

Temazepam, nitrazepam and zopiclone are the most frequently prescribed hypnotics in the United Kingdom. Hypnotic drugs are of poor value for the management of chronic insomnia. It is widely accepted that hypnotic drug usage beyond 4 weeks is undesirable for all age groups of patients. Many continuous sedative hypnotic users exhibit disturbed sleep as a consequence of tolerance but experience worsening rebound or withdrawal insomnia when the dose is reduced too quickly which compounds the problem of chronic hypnotic drug use. Chronic hypnotic drug consumption has been shown to reduce work performance increase absenteeism increase road traffic accidents, increased morbidity, increased mortality and is associated with increased deliberate self harm. In the elderly increases in falls and fractures associated with sedative hypnotic drug use has been found. CBT have been found to be more effective for the long term management of insomnia than sedative hypnotic drugs. No formal withdrawal programs for benzodiazepines exists with local providers. A meta-analysis of published data on psychological treatments for insomnia show a success rate between 70 and 80%. A large scale trial utilising cognitive behavioural therapy in chronic users of sedative hypnotics including nitrazepam, temazepam and zopiclone found that CBT to be a more effective long term treatment for chronic insomnia. Persisting improvements in sleep quality, sleep latency, increased total sleep, improvements in sleep efficiency, significant improvements in vitality, physical and mental health at 3, 6 and 12 month follow up was found in those receiving cognitive behavioural therapy. A marked reduction in total sedative hypnotic drug use was found in those receiving CBT, with 33% reporting zero hypnotic drug use. Age has been found not to be a barrier to successful outcome of CBT. It was concluded that CBT for the management of chronic insomnia was flexible, practical and cost effective treatment for the treatment of insomnia and that CBT leads to a reduction of benzodiazepine drug intake in significant number of patients.[33]

Toxicity

Benzodiazepines are generally thought to be safe in overdose.[34] Death after admission is rare and due to respiratory depression with aspiration of gastric contents.[35] Over 10 years in the United Kingdom, however, 1512 fatal poisonings have been attributed to benzodiazepines with or without alcohol.[36] These were compared with prescription data to establish a fatal toxicity index (deaths per million prescriptions) for each benzodiazepine. Similar indices have been derived for antidepressants[37] and barbiturates.[38] There were clear differences between benzodiazepines. Of drugs frequently prescribed, temazepam by far had the highest number of deaths per million prescriptions at 11.9 (95% confidence interval 10.9 to 12.8); above that of some tricyclic antidepressants.[39][40] In contrast, oxazepam had an index of 2.3 (1.2 to 3.4), and the average index for all benzodiazepines combined was 5.7.

Although there are potential sources of error in these studies,[41] a bias that would lead to differences between compounds was not identified.[42] Clinical studies can adjust for potential confounders which studies that use coronial data are unable to take into account. If differences between the benzodiazepines are supported by data from clinical studies this also adds credence to the fatal toxicity index which first noted these findings.

The aim was therefore to determine if temazepam caused more sedation and oxazepam less sedation than other benzodiazepines.

During 1991-3, 542 patients with benzodiazepine poisoning presented to the hospital, 239 of these patients, however, had ingested either more than one benzodiazepine or coingested other sedating drugs. The drugs ingested by the remainder were temazepam (64), oxazepam (45), diazepam (113), clonazepam (24), flunitrazepam (21), nitrazepam (18), others (18).

Details of coma scores and odds ratios of the benzodiazepines ingested showed that temazepam was significantly more toxic than most other benzodiazepines.[43] 2 out of the 45 subjects (4%) who ingested oxazepam were stuporous or comatose, 38 out of the 194 subjects (19%) who ingested other benzodiazepines (clonazepam, diazepam, flunitrazepam, nitrazepam and others) were stuporous or comatose, while 16 out of the 64 subjects (25%) who ingested temazepam were stuporous or comatose. None of the oxazepam subjects were comatose, 16 out of the 194 subjects (8%) who ingested other benzodiazepines were fully comatose, and 9 out of 64 subjects (14%) who ingested temazepam were fully comatose.

The results show that there are differences between temazepam, oxazepam, and other benzodiazepines in the degree of sedation they cause in overdose, and the observed differences are not due to confounding by age, sex, dose ingested, coingestion of alcohol, chronic benzodiazepine use, or history of drug or alcohol abuse. This provides a plausible explanation why temazepam and oxazepam have different fatal toxicity indices from other benzodiazepines.[44]

The sedation produced by benzodiazepines in therapeutic doses and overdose has a poor correlation with measured drug concentration but is increased with rapid absorption.[45][46][47][48] Temazepam is more rapidly absorbed and oxazepam is more slowly absorbed than other benzodiazepines.[49][50][51][52][53] Further research is required to determine if the rate of absorption is different in overdose and is sufficient to explain the differences in sedation. Slowing the rate of absorption may reduce toxicity, but this would also reduce their sedative effect in therapeutic doses.[54] Drug regulatory authorities should be aware that changes in formulation of benzodiazepines may affect toxicity in overdose.

Pharmacodynamic factors such as benzodiazepine receptor affinity and potency may also be important. Because of the wide variations in half life, adjustments for dose by conversion into defined daily doses or diazepam equivalents[55]is imperfect. These are designed to compare use rather than potency. Though they correlate reasonably well with sizes of prescriptions and tablets, they may not account for potency pertablet taken in overdose.[56]

Abuse and misuse

In Australia, temazepam accounts for most benzodiazepine sought by forgery of prescriptions and through pharmacy burglary. Pharmacists and their staff often encounter aggressive and threatening behaviour from people seeking temazepam. There were 537 burglaries on Victoria's 1200 pharmacies from 1 January to 30 August 2001, including 'ram raids' (using stolen cars to smash through windows). Temazepam appears to be the main target in many pharmacy burglaries. Temazepam is sought in 85% of all reported benzodiazepine forgeries.[57]

Unprescribed temazepam is often detected in urine samples of drug misusers which suggests a high misuse potential of temazepam.[58] Studies suggest that temazepam is a particularily euphoric benzodiazepine, and along with other hypnotic benzodiazepines, particularily, flunitrazepam, nitrazepam, and nimetazepam, it is considered to have the highest abuse potential of all benzodiazepines. In the UK, temazepam has superseded diazepam, nitrazepam and flurazepam as the most commonly abused benzodiazepine, in line with the increase in temazepam prescriptions and possibly (until recently) because of the availability of easily injectable forms of temazepam from capsules, 'jellies', 'eggs' (Stark et al. 1987). Benzodiazepines have been injected but at present temazepam is mainly involved. Strang et al. (1994) conducted a questionnaire survey of subjects attending drug clinics in seven British cities. Of 208 subjects returning the questionnaire, 186 had used benzodiazepines and 103 had injected them intravenously. Temazepam was the most commonly used and had been injected from preparations of capsules, tablets and syrup.[1]

Temazepam (whether obtained from capsules, tablets or elixir), is extremely irritating and likely to cause tissue damage. When arm veins become occluded due to local irritation, users may proceed to injecting in the groin, where inadvertent intra-arterial injection has led to amputation. The severity of the addiction which can develop to temazepam is illustrated by the case of a temazepam injector who needed his leg amputated but was later admitted for a second amputation since he had continued injecting into his remaining leg (Parrott 1995). A second subject, following a leg amputation, injected temazepam gel into his eye, resulting in bilateral blindness. [2]

In Northern Ireland in cases where drugs were found in tests on impaired drivers who had low alcohol readings but were suspected of driving under the influence of drugs benzodiazepines were found to be present in 87% of cases, with temazepam accounting for the vast majority of cases.[59]

Side effects

Common side effects include

CNS depression typical of hypnotic benzodiazepine are common and include, somnolence, dizziness, fatigue, ataxia, headache, lethargy, impairment of memory, impairment of motor functions, slurred speech, decreased physical performance, numbed emotions, reduced alertness, muscle weakness, blurred vision, and inattention. Euphoria, which is very uncommon among the vast majority of benzodiazepines, was consistently reported with the use of temazepam. According to the FDA, temazepam had one of the highest incidences of euphoria among the few benzodiazepines that reported it during clinical trials.[60]. Unpleasant dreams and rebound insomnia have also been reported. High levels of confusion, clumsiness also occurs after administration of temazepam.[61] Increased reaction time, co-ordination problems and impaired learning and memory.[62]

Less Common Side Effects=

Hyperhidrosis, hypotension, burning eyes, changes in libido, hallucinations, faintness, horizontal nystagmus, vomiting, pruritus, gastrointestinal disturbances, nightmares, palpitation and paradoxical reactions including restlessness, aggression, violence, overstimulation and agitation have been reported, but are rare (less than 0.5%).

Before taking temazepam, one should ensure that at least 8 hours are available to dedicate to sleep. Failing to do so can increase the side effects of the drug.

Long-term use of temazepam can result in psychological and physical dependence and the appearance of benzodiazepine withdrawal symptoms when the drug is discontinued or the dose reduced. Temazepam impairs cognitive and psychomotor functions, affecting reaction time and driving skill. The use of this drug in combination with alcohol potentiates these side effects, and can lead to toxicity and death.

Though rare, residual 'hangover' effects after nighttime administration of temazepam such as sleepiness, impaired psychomotor and cognitive functions may persist into the next day which may impair the ability of users to drive safely or may increase the risks of falls and hip fractures.[65]

Interactions

See Diazepam#Interactions.

Contraindications

Use of temazepam should be avoided, when possible, in individuals with the following conditions:

Special caution needed

  • Pregnant Women - temazepam may cause fetal damage when administered during pregnancy.
  • Pediatric patients
    • Less than 18 years of age - Safety and effectiveness have not been established; temazepam should generally not be given to individuals under 18 years of age
    • Under 6 months of age - Safety and effectiveness have not been established; temazepam should not be given to individuals in this age group.
  • Elderly and very ill patients - Possibility that apnea and/or cardiac arrest may occur. Concomitant use of other central nervous system depressants increases this risk. The smallest possible effective dose should be used for this group of patients.

Pregnancy

Temazepam belongs to the Pregnancy Category X of the FDA, and as such it is known to cause serious birth defects and fetal abnormalities. Temazepam increased risk of congenital malformations associated with the use of benzodiazepines during the first trimester of pregnancy has been suggested in several studies. Transplacental distribution has resulted in neonatal CNS depression following the ingestion of therapeutic doses of a benzodiazepine hypnotic during the last weeks of pregnancy.

Reproduction studies in animals with Temazepam were performed in rats and rabbits. In a perinatal-postnatal study in rats, oral doses of 60 mg/kg/day resulted in increasing nursling mortality. Teratology studies in rats demonstrated increased fetal resorptions at doses of 30 and 120 mg/kg in one study and increased occurrence of rudimentary ribs, which are considered skeletal variants, in a second study at doses of 240 mg/kg or higher. In rabbits, occasional abnormalities such as exencephaly and fusion or asymmetry of ribs were reported without dose relationship. Although these abnormalities were not found in the concurrent control group, they have been reported to occur randomly in historical controls. At doses of 40 mg/kg or higher, there was an increased incidence of the 13th rib variant when compared to the incidence in concurrent and historical controls.

Temazepam is contraindicated in pregnant women. If there is a likelihood of the patient becoming pregnant while receiving Temazepam, she should be warned of the potential risk to the fetus. Patients should be instructed to discontinue the drug prior to becoming pregnant. The possibility that a woman of childbearing potential may be pregnant at the time of institution of therapy should be considered.[66]

Patients at a high risk for abuse and dependence

Temazepam can lead to physiological tolerance, and psychological and/or physical dependence. At a particularly high risk for temazepam misuse, abuse, and dependence are:

  • Patients with a history of alcohol or drug abuse or dependence
  • Emotionally unstable patients
  • Patients with severe personality disorders, such as Borderline Personality Disorder
  • Patients with chronic pain or other physical disorders

Patients from the aforementioned groups should be monitored very closely during therapy for signs of abuse and development of dependence. Discontinue therapy if any of these signs are noted. Long-term therapy in these patients is not recommended.

Overdose

Manifestations of acute overdosage of temazepam can be expected to reflect the increasing CNS effects of the drug and include:

  • Somnolence (difficulty staying awake)
  • Mental confusion
  • Respiratory depression
  • Hypotension
  • Impaired motor functions
    • Impaired or absent reflexes
    • Impaired coordination
    • Impaired balance
    • Dizziness
  • Coma
  • Death

Temazepam overdose is considered a serious medical emergency and generally requires the immediate attention of medical personnel. The antidote for an overdose of temazepam (or any other benzodiazepine) is flumazenil (Anexate®).

If the patient is conscious, vomiting should be induced mechanically or with emetics (e.g., syrup of ipecac 20 to 30 mL). Gastric lavage should be employed as soon as possible, utilizing concurrently a cuffed endotracheal tube if the patient is unconscious, in order to prevent aspiration and pulmonary complications. Maintenance of adequate pulmonary ventilation is essential and fluids should be administered IV to encourage diuresis. The use of pressor agents IV, may be necessary to combat hypotension but only if considered essential. The value of dialysis in emergency therapy for benzodiazepine overdosage has not been determined. If excitation occurs, barbiturates should not be used. It should be borne in mind that multiple agents may have been ingested.

The oral LD50 of temazepam was 1963 mg/kg in mice, 1833 mg/kg in rats, and >2400 mg/kg in rabbits.

Temazepam is a drug which is very frequently involved in drug intoxication, including overdose.[67] Overdose of temazepam may result in excessive sedation, impairment of balance and speech. This may progress in severe overdoses to respiratory depression or coma and possibly death. The risk of overdose is increased if temazepam is taken in combination with alcohol, opiates or other CNS depressants. Temazepam overdose responds to the benzodiazepine receptor antagonist flumazenil.

Benzodiazepines were implicated in 39% of suicides by drug poisoning in Sweden, with temazepam, nitrazepam and flunitrazepam accounting for 90% of benzodiazepine implicated suicides, in the elderly over a period of 2 decades. In three quarters of cases death was due to drowning, typically in the bath. Benzodiazepines were the predominant drug class used in suicides in this review of Swedish death certificates with 72% of benzodiazepine overdoses showing that benzodiazepines were the sole drug used in deaths by overdose. Benzodiazepines and in particular temazepam, nitrazepam and flunitrazepam should therefore be prescribed with caution in the elderly.[68] Nitrazepam, and especially temazepam were the benzodiazepines most commonly detected in overdose related drug deaths in an Australian study of drug deaths. Benzodiazepines were found to be the sole cause of death in one third of cases.[69]

In a retrospective study of deaths, when benzodiazepines were implicated in the deaths, the benzodiazepines flunitrazepam, temazepam and nitrazepam were the most common benzodiazepines involved. Benzodiazepines were a factor in all deaths caused by drug addiction in the study. Temazepam, nitrazepam and flunitrazepam were significantly more commonly implicated in suicide related deaths than natural deaths. In four of the cases benzodiazepines alone were the only cause of death. It was concluded that flunitrazepam and temazepam were significantly more toxic than other benzodiazepines.[70]

From a research perspective, there are some data suggesting that temazepam may be more frequently involved in drug-related deaths (worldwide) than are some other benzodiazepines. Temazepam produced more sedation than did other benzodiazepines, in overdose situations. Thus, there is some reason to think that temazepam (once taken in overdose) may have greater toxicity than other benzodiazepines. [71]

In the United Kingdom, the drug is available only by private prescription. Temazepam is a Class B drug in the United Kingdom and possession is illegal without a prescription. Additionally, all manufacturers in the UK have replaced the gel-capsules with solid tablets.

In the US, temazepam is a Schedule IV drug and is only available by prescription. Temazepam is the only benzodiazepine which requires specially coded prescriptions in certain States.

Internationally, temazepam is a Schedule IV drug under the Convention on Psychotropic Substances[3].

In Canada, Temazepam is a Schedule IV controlled substance requiring a doctors prescription.

In Ireland, Temazepam is a Schedule 3 controlled substance with strict restrictions.[72]

In Australia, temazepam in liquid form is restricted as a Schedule 8 controlled drug. As a Schedule 8 controlled substance, it is illegal to have this drug in possession without an authority prescription from a registered doctor. In tablet form, it is a Schedule 4 prescription only medicine.

In South Africa, temazepam is a Schedule 6 drug, requiring a prescription, and restricted to 10-20 mg doses.

In Hong Kong, Temazepam is regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance. It can only be used legally by health professionals and for university research purporses. The substance can be given by pharmacists under a prescription. Anyone who supplies the substance without prescription can be fined $10000 (HKD). The penalty for trafficking or manufacturing the substance is a $5,000,000 (HKD) fine and life imprisonment. Possession of the substance for consumption without license from the Department of Health is illegal with a $1,000,000 (HKD) fine and/or 7 years of jail time. More information can be found: [4]

Temazepam tablets are called Jellies, Tams, Terms, Temazzies, Eggs, Green Eggs, Norries, and Rugby balls.

The recreational effects of the drug were documented on the Black Grape album, It's Great When You're Straight... Yeah. The track 'Tramazi Parti' contains the lyric: I got my boots on the back of my head / It's full of jellies in the good old bed / And no one knows what no one said. Although there is no medical research confirming this behaviour, it is not inconsistent with the known side effects of the drug.

On the BBC radio series The Archers, Jolyon Gibson's Christmas present to Kate was a bottle of temazepam capsules. Feeling depressed on New Year's Eve 1995, Kate took whisky and the "jellies" together and ended up in hospital.[5]

See also

References

  1. ^ Yasui M (2005). "[Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes]". 25 (3): 143–51. PMID 16045197. {{cite journal}}: Cite journal requires |journal= (help); Text "Nihon Shinkei Seishin Yakurigaku Zasshi." ignored (help)
  2. ^ Rickels K. (1986). "The clinical use of hypnotics: indications for use and the need for a variety of hypnotics". Acta Psychiatr Scand Suppl. 332: 132–41. PMID 2883820.
  3. ^ O'Neal, Maryadele J. Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. Merck. October 18, 2006.
  4. ^ Yevgenia Albats and Catherine A. Fitzpatrick. The State Within a State: The KGB and Its Hold on Russia - Past, Present, and Future. 1994.
  5. ^ See: Sidney Bloch and Peter Reddaway (1984). Soviet Psychiatric Abuse: The Shadow over World Psychiatry. Victor Gollancz, London.
  6. ^ http://teacher.scholastic.com/scholasticnews/indepth/headsup/support/prescription.pdf
  7. ^ http://www.drugscope.org.uk/resources/faqs/faqpages/what-are-the-uk-drug-laws.htm
  8. ^ Woody GE (1979). "Development of psychiatric illness in drug abusers. Possible role of drug preference". The New England journal of medicine. 301 (24): 1310–4. PMID 41182. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  9. ^ http://www.emeraldinsight.com/Insight/viewContentItem.do;jsessionid=4D1454C1B212C88BC78C006F3DDB1EBD?contentType=Article&hdAction=lnkhtml&contentId=872698
  10. ^ http://linkinghub.elsevier.com/retrieve/pii/S0379073800002735
  11. ^ "Benzodiazepine use and harms among police detainees in Australia" (PDF). Australian Institute of Criminology. May 2007. {{cite web}}: |first= missing |last= (help); Missing pipe in: |first= (help)
  12. ^ Oelschläger H. (4). "[Chemical and pharmacologic aspects of benzodiazepines]". Schweiz Rundsch Med Prax. 78 (27–28): 766–72. PMID 2570451. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Cite has empty unknown parameter: |coauthors= (help); Unknown parameter |month= ignored (help)
  13. ^ Professor heather Ashton (2007). "BENZODIAZEPINE EQUIVALENCY TABLE". {{cite web}}: Unknown parameter |accessmonthday= ignored (help); Unknown parameter |accessyear= ignored (|access-date= suggested) (help); Unknown parameter |month= ignored (help)
  14. ^ Vozeh S. (21). "[Pharmacokinetic of benzodiazepines in old age]". Schweiz Med Wochenschr. 111 (47): 1789–93. PMID 6118950. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Cite has empty unknown parameter: |coauthors= (help); Unknown parameter |month= ignored (help)
  15. ^ Shats V (1). "[Falls in the geriatric department: responsibility of the care-giver and the hospital]". Harefuah. 128 (11): 690–3. PMID 7557666. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  16. ^ Rooke KC. (1976). "The use of flurazepam (dalmane) as a substitute for barbiturates and methaqualone/diphenhydramine (mandrax) in general practice". J Int Med Res. 4 (5): 355–9. PMID 18375. {{cite journal}}: Cite has empty unknown parameters: |month= and |coauthors= (help)
  17. ^ >F. O. Müller (2). "Pharmacokinetics of temazepam after day-time and night-time oral administration". 33 (2): 211–214. doi:10.1007/BF00544571. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Cite journal requires |journal= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  18. ^ http://www.rxlist.com/cgi/generic/temaz_cp.htm
  19. ^ >Schwarz HJ (1). "Pharmacokinetics and metabolism of temazepam in man and several animal species". 23 (29). PMID 41539. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Cite journal requires |journal= (help); Unknown parameter |month= ignored (help)
  20. ^ >L. M. Fuccella (20). "Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules". 12 (5): 383–386. doi:10.1007/BF00562455. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Cite journal requires |journal= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  21. ^ http://www.rxlist.com/cgi/generic/temaz_cp.htm
  22. ^ Mant A (1993). "Benzodiazepine utilisation in Australia: report from a new pharmacoepidemiological database". Aust J Public Health. 17 (4): 345–9. PMID 7911332. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  23. ^ Cook PJ (8). "Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam" (pdf). Br Med J (Clin Res Ed). 286 (6359): 100-2. PMID 6129914. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  24. ^ MacKinnon GL (1982). "Benzodiazepine withdrawal syndrome: a literature review and evaluation". The American journal of drug and alcohol abuse. 9 (1): 19–33. PMID 6133446. {{cite journal}}: Cite has empty unknown parameter: |month= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  25. ^ Hecker R (1992). "Risk of benzodiazepine dependence resulting from hospital admission". Drug Alcohol Rev. 11 (2): 131–5. PMID 16840267. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  26. ^ Hindmarch I. (1977). "A repeated dose comparison of three benzodiazepine derivative (nitrazepam, temazepam and flunitrazepam) on subjective appraisals of sleep and measures of psychomotor performance the morning following night-time medication". Acta Psychiatr Scand. 56 (5): 373–81. PMID 22990. {{cite journal}}: Cite has empty unknown parameter: |coauthors= (help); Unknown parameter |month= ignored (help)
  27. ^ Viukari M (1978). "Efficacy and side effects of flurazepam, temazepam, and nitrazepam as sleeping aids in psychogeriatric patients". Acta Psychiatr Scand. 57 (1): 27–35. PMID 24980. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  28. ^ Nowakowska E (1987). "Differences in the development of tolerance to various benzodiazepines". Pol J Pharmacol Pharm. 39 (3): 245–52. PMID 2894019. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  29. ^ Terao T (1). "[Two cases of psychotic state following normal-dose benzodiazepine withdrawal]". J UOEH. 10 (3): 337–40. PMID 2902678. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  30. ^ Tagashira E (1981). "Enhancement of drug withdrawal convulsion by combinations of phenobarbital and antipsychotic agents". Jpn J Pharmacol. 31 (5): 689–99. PMID 6118452. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  31. ^ Terao T (15). "Depersonalization following temazepam withdrawal". Biol Psychiatry. 31 (2): 212–3. PMID 1737083. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  32. ^ Kitabayashi Y (2001). "Chronic high-dose nitrazepam dependence 123I-IMP SPECT and EEG studies". Addict Biol. 6 (3): 257–261. PMID 11900604. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  33. ^ Morgan K (2004). "Psychological treatment for insomnia in the regulation of long-term hypnotic drug use" (PDF). Health Technol Assess. 8 (8). National Institute for Health Research: 1–68. PMID 14960254. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  34. ^ Gaudreault P, Guay J, Thivierge RL, Verdy I. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment. Drug Safety 1991;6:247-65.
  35. ^ Hojer J, Baehrendtz S, Gustafsson L. Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14 year period. J Intern Med 1989;226:117-22.
  36. ^ Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993;163:386-93.
  37. ^ Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987;295:1021-4.
  38. ^ Johns MW. Self poisoning with barbiturates in England and Wales during 1959-74. BMJ 1977;i:1128-30.
  39. ^ Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993;163:386-93.
  40. ^ Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987;295:1021-4.
  41. ^ Dwyer PS, Jones IF. Fatal self-poisoning in the UK and the paracetamol/ detropropoxyphene combination. Human Toxicology 1984;3(suppl): 145-174S.
  42. ^ Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993;163:386-93.
  43. ^ http://www.bmj.com/cgi/content/full/310/6974/219
  44. ^ Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993;163:386-93.
  45. ^ Gaudreault P, Guay J, Thivierge RL, Verdy I. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment. Drug Safety 1991;6:247-65.
  46. ^ Busto U, Kaplan HL, Sellers EM. Benzodiazepine associated emergencies in Toronto. Am J Psychiatry 1980;137:224-7.
  47. ^ Fucella LM, Bolcioni G, Tamassia V, Ferrario L, Tognoni G. Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol 1977;12:383-6.
  48. ^ Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Arch Gen Psychiatr 1989;46:326-32.
  49. ^ Gaudreault P, Guay J, Thivierge RL, Verdy I. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment. Drug Safety 1991;6:247-65.
  50. ^ Busto U, Kaplan HL, Sellers EM. Benzodiazepine associated emergencies in Toronto. Am J Psychiatry 1980;137:224-7.
  51. ^ Fucella LM, Bolcioni G, Tamassia V, Ferrario L, Tognoni G. Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol 1977;12:383-6.
  52. ^ Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Arch Gen Psychiatr 1989;46:326-32.
  53. ^ Mitler MM. Evaluation of temazepam as a hypnotic. Pharmacotherapy 1981;1:3-13.
  54. ^ Fucella LM, Bolcioni G, Tamassia V, Ferrario L, Tognoni G. Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol 1977;12:383-6.
  55. ^ Alexander B, Perry PJ. Detoxification from benzodiazepines: schedules and strategies. J Subst Abuse Treat 1991;8:9-17.
  56. ^ Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br J Psychiatry 1993;163:386-93.
  57. ^ http://www.health.vic.gov.au/drugservices/pubs/temazepam/facts.htm
  58. ^ Garretty DJ (1997). "Benzodiazepine misuse by drug addicts". Annals of clinical biochemistry. 34 (Pt 1): 68–73. PMID 9022890. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  59. ^ Cosbey SH. (1986). "Drugs and the impaired driver in Northern Ireland: an analytical survey". Forensic Sci Int. 32 (4): 245–58. PMID 3804143. {{cite journal}}: Unknown parameter |month= ignored (help)
  60. ^ http://www.drugs.com/pro/temazepam.html
  61. ^ Sanders LD (1988). "A double-blind comparison between nitrazepam, lorazepam, lormetazepam and placebo as preoperative night sedatives". Eur J Anaesthesiol. 5 (6): 377–83. PMID 2907315. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  62. ^ Liljequist R (1979). "Acute effects of temazepam and nitrazepam on psychomotor skills and memory". Acta Pharmacol Toxicol (Copenh). 44 (5): 364–9. PMID 38627. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  63. ^ a b Liljequist R (1979). "Acute effects of temazepam and nitrazepam on psychomotor skills and memory". Acta Pharmacol Toxicol (Copenh). 44 (5): 364–9. PMID 38627. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  64. ^ http://www.drugs.com/pro/temazepam.html
  65. ^ Vermeeren A. (2004). "Residual effects of hypnotics: epidemiology and clinical implications". CNS Drugs. 18 (5): 297–328. PMID 15089115. {{cite journal}}: Cite has empty unknown parameters: |month= and |coauthors= (help)
  66. ^ http://www.drugs.com/pro/temazepam.html
  67. ^ Zevzikovas A (2002). "[Analysis of benzodiazepine derivative mixture by gas-liquid chromatography]". Medicina (Kaunas). 38 (3): 316–20. PMID 12474705. {{cite journal}}: Cite has empty unknown parameter: |month= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  68. ^ Carlsten, A (2003). "The role of benzodiazepines in elderly suicides". Scand J Public Health. 31 (3): 224–8. PMID 12850977. {{cite journal}}: Cite has empty unknown parameter: |month= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  69. ^ Drummer OH (1996). "Sudden death and benzodiazepines". Am J Forensic Med Pathol. 17 (4): 336–42. PMID 8947361. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  70. ^ Ericsson HR (10). "[Benzodiazepine findings in autopsy material. A study shows interacting factors in fatal cases]". Läkartidningen. 90 (45): 3954–7. PMID 8231567. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  71. ^ http://www.a1b2c3.com/drugs/benz12.htm
  72. ^ http://www.irishstatutebook.ie/1993/en/si/0342.html
Retrieved from "https://en.wikipedia.org/w/index.php?title=Temazepam&oldid=172746904"